Evidence map›Paper›PMID 38405499›Full record

ArticleACS omega2024

EGGNet, a Generalizable Geometric Deep Learning Framework for Protein Complex Pose Scoring.

Zichen Wang, Ryan Brand, Jared Adolf-Bryfogle, Jasleen Grewal, Yanjun Qi, Steven A Combs, Nataliya Golovach, Rebecca Alford, Huzefa Rangwala, Peter M Clark

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zichen WangAmazon Web Services, Amazon, Seattle, Washington 98109-5210, United States.ORCID https://orcid.org/0000-0002-1415-1286
Ryan BrandAmazon Web Services, Amazon, Seattle, Washington 98109-5210, United States.
Jared Adolf-BryfogleJanssen Biotherapeutics, Janssen Pharmaceutical Companies of Johnson & Johnson, Spring House, Titusville, New Jersey 08560-1504, United States.
Jasleen GrewalAmazon Web Services, Amazon, Seattle, Washington 98109-5210, United States.ORCID https://orcid.org/0000-0001-7213-5930
Yanjun QiAmazon Web Services, Amazon, Seattle, Washington 98109-5210, United States.
Steven A CombsJanssen Biotherapeutics, Janssen Pharmaceutical Companies of Johnson & Johnson, Spring House, Titusville, New Jersey 08560-1504, United States.
Nataliya GolovachJanssen Biotherapeutics, Janssen Pharmaceutical Companies of Johnson & Johnson, Spring House, Titusville, New Jersey 08560-1504, United States.
Rebecca AlfordJanssen Biotherapeutics, Janssen Pharmaceutical Companies of Johnson & Johnson, Spring House, Titusville, New Jersey 08560-1504, United States.
Huzefa RangwalaAmazon Web Services, Amazon, Seattle, Washington 98109-5210, United States.
Peter M ClarkJanssen Biotherapeutics, Janssen Pharmaceutical Companies of Johnson & Johnson, Spring House, Titusville, New Jersey 08560-1504, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computational prediction of molecule-protein interactions has been key for developing new molecules to interact with a target protein for therapeutics development. Previous work includes two independent streams of approaches: (1) predicting protein-protein interactions (PPIs) between naturally occurring proteins and (2) predicting binding affinities between proteins and small-molecule ligands [also known as drug-target interaction (DTI)]. Studying the two problems in isolation has limited the ability of these computational models to generalize across the PPI and DTI tasks, both of which ultimately involve noncovalent interactions with a protein target. In this work, we developed Equivariant Graph of Graphs neural Network (EGGNet), a geometric deep learning (GDL) framework, for molecule-protein binding predictions that can handle three types of molecules for interacting with a target protein: (1) small molecules, (2) synthetic peptides, and (3) natural proteins. EGGNet leverages a graph of graphs (GoG) representation constructed from the molecular structures at atomic resolution and utilizes a multiresolution equivariant graph neural network to learn from such representations. In addition, EGGNet leverages the underlying biophysics and makes use of both atom- and residue-level interactions, which improve EGGNet's ability to rank candidate poses from blind docking. EGGNet achieves competitive performance on both a public protein-small-molecule binding affinity prediction task (80.2% top 1 success rate on CASF-2016) and a synthetic protein interface prediction task (88.4% area under the precision-recall curve). We envision that the proposed GDL framework can generalize to many other protein interaction prediction problems, such as binding site prediction and molecular docking, helping accelerate protein engineering and structure-based drug development.

Identifiers

PMID38405499
PMCPMC10882658

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.